Abstract:
:Ectopic calcification of soft tissues can have severe clinical consequences especially when localized to vital organs such as heart, arteries and kidneys. Mammalian stanniocalcin (STC) 1 and 2 are glycoprotein hormones identified as calcium/phosphate-regulating hormones. The mRNA of STCs is upregulated in the kidney of α-klotho mutant (kl/kl) mice, which have hypercalcemia, hyperphosphatemia and hypervitaminosis D and exhibit a short life span, osteopenia and ectopic calcification. In the present study, we investigated the distribution and localization of STCs in kl/kl mice. Quantitative RT-PCR revealed that renal mRNA expression of STC2 was increased in both kl/kl mice and fibroblast growth factor 23 (Fgf23)-null mice compared with wild type mice. Interestingly, STC2 protein was focally localized with the calcified lesions of renal arterioles, renal tubular cells, heart and aorta in kl/kl mice. In vitro analysis of rat aortic vascular smooth muscle (A-10) cells showed that inorganic phosphate (Pi) stimulation significantly increased STC2 mRNA levels as well as that of osteocalcin, osteopontin and the type III sodium-dependent phosphate co-transporter (PiT-1), and induced STC2 secretion. Interestingly, the knockdown with a small interfering RNA or the over-expression of STC2 showed acceleration and inhibition of Pi-induced calcification in A-10 cells, respectively. These results suggest that the up-regulation of STC2 gene expression resulting from abnormal α-klotho-Fgf23 signaling may contribute to limitation of ectopic calcification and thus STC2 represents a novel target gene for cardio-renal syndrome.
journal_name
Bonejournal_title
Boneauthors
Takei Y,Yamamoto H,Sato T,Otani A,Kozai M,Masuda M,Taketani Y,Muto-Sato K,Lanske B,Takeda Edoi
10.1016/j.bone.2012.01.006subject
Has Abstractpub_date
2012-04-01 00:00:00pages
998-1005issue
4eissn
8756-3282issn
1873-2763pii
S8756-3282(12)00016-6journal_volume
50pub_type
杂志文章相关文献
BONE文献大全abstract::The effects of tumor-conditioned media (TCM) derived from cultured cells from an oncogenic hypophosphatemic osteomalacia (OHO) tumor on transformed human kidney cells were investigated. Dose-dependent cell detachment and aggregation occurred in kidney cells cultured in serum-free medium supplemented with TCM, but not ...
journal_title:Bone
pub_type: 杂志文章
doi:10.1016/8756-3282(95)00458-0
更新日期:1996-02-01 00:00:00
abstract:OBJECTIVE:Osteoarthritis (OA) is a joint disease characterized by progressive degeneration of articular cartilage. Some features of OA, including chondrocyte hypertrophy and focal calcification of articular cartilage, resemble the endochondral ossification processes. Alterations in transforming growth factor β (TGFβ) s...
journal_title:Bone
pub_type: 杂志文章
doi:10.1016/j.bone.2018.07.008
更新日期:2018-11-01 00:00:00
abstract::Osteocytes, the most abundant cells in the cortical bone matrix, are thought to have mechanosensory and chemosensory regulatory roles. Marotti theorized that osteocytes signal to osteoblasts to recruit them into the osteocyte lineage. Martin extended this theory, assuming that osteocytes display a general inhibitory e...
journal_title:Bone
pub_type: 杂志文章
doi:10.1016/s8756-3282(03)00245-x
更新日期:2003-11-01 00:00:00
abstract::Several Biophosphonates have been used as therapeutic agents for Paget's bone disease. (Chloro-4 phenyl)thiomethylene-bisphosphonate (CIPsMBP) has recently been shown to have significant antiosteoclastic activity while an affect of CIPsMBP on mineralization was only observed at high doses. We tested this drug for 6 mo...
journal_title:Bone
pub_type: 临床试验,杂志文章
doi:10.1016/8756-3282(88)90115-9
更新日期:1988-01-01 00:00:00
abstract::Changes in skeletal remodeling (biochemical bone markers) and regional bone mineral density (spine, hip, and forearm bone mineral density [BMD]) were observed for 3 years in 20 patients (15 women and 5 men; age 54 +/- 11 years, range 29-69 years) after successful surgery for primary hyperparathyroidism (PHPT). Fifteen...
journal_title:Bone
pub_type: 临床试验,杂志文章
doi:10.1016/s8756-3282(99)00207-0
更新日期:1999-11-01 00:00:00
abstract::Active vitamin D is a major therapeutic agent for bone disease. Although some studies have reported that vitamin D ameliorates bone disease related to diabetes, the mechanism remains unclear. Our study investigated the effect of the vitamin D receptor activator 22-oxacalcitriol (OCT) on bone disease in a rat model of ...
journal_title:Bone
pub_type: 杂志文章
doi:10.1016/j.bone.2015.01.014
更新日期:2015-05-01 00:00:00
abstract:PURPOSE:In the Fracture Prevention Trial, the risks of any nonvertebral fracture (relative risk [RR] 0.65, P=0.04) and any fragility nonvertebral fracture (RR 0.47, P=0.02) were significantly reduced in the teriparatide 20 μg/day (teriparatide) versus placebo group. The purpose of this analysis was to examine the effic...
journal_title:Bone
pub_type: 杂志文章,随机对照试验
doi:10.1016/j.bone.2011.10.018
更新日期:2012-01-01 00:00:00
abstract::Bone matrix, mainly composed of type I collagen and apatite, is constantly modified during the bone remodeling process, which exposes bone cells to various proportions of mineralized collagen within bone structural units. Collagen-mineralized substrates have been shown to increase osteoblast activities. We hypothesize...
journal_title:Bone
pub_type: 杂志文章
doi:10.1016/j.bone.2010.03.010
更新日期:2010-07-01 00:00:00
abstract::Endoplasmic reticulum (ER) stress is associated with increased reactive oxygen species (ROS), results from accumulation of misfolded/unfolded proteins, and can trigger apoptosis. ER stress is alleviated by phosphorylation of eukaryotic translation initiation factor 2α (eIF2α), which inhibits protein translation allowi...
journal_title:Bone
pub_type: 杂志文章
doi:10.1016/j.bone.2014.12.012
更新日期:2015-04-01 00:00:00
abstract::Evidence indicates that astronauts experience significant bone loss during space mission. Recently, we used the NASA developed rotary cell culture system (RCCS) to simulate microgravity (μXg) conditions and demonstrated increased osteoclastogenesis in mouse bone marrow cultures. Autophagy is a cellular recycling proce...
journal_title:Bone
pub_type: 杂志文章
doi:10.1016/j.bone.2014.01.004
更新日期:2014-04-01 00:00:00
abstract:UNLABELLED:We identified regions inside the proximal femur that are most strongly associated with hip fracture. Bone densitometry based on such fracture-critical regions showed improved power in discriminating fracture patients from controls. INTRODUCTION:Hip fractures typically occur in lateral falls, with focal mech...
journal_title:Bone
pub_type: 杂志文章
doi:10.1016/j.bone.2008.12.008
更新日期:2009-04-01 00:00:00
abstract::Daily subcutaneous administration of exogenous parathyroid hormone (PTH) promotes bone formation in patients with osteoporosis. Here we describe two novel, short-acting calcium-sensing receptor antagonists (SB-423562 and its orally bioavailable precursor, SB-423557) that elicit transient PTH release from the parathyro...
journal_title:Bone
pub_type: 杂志文章,随机对照试验
doi:10.1016/j.bone.2009.09.028
更新日期:2010-02-01 00:00:00
abstract::As the world's population ages, the occurrence of osteoporosis-related fractures is projected to increase. Low areal bone mineral density (aBMD), a well-known risk factor for fractures, may be influenced by physical activity (PA). In this cross-sectional study, we aimed to investigate potential associations between ob...
journal_title:Bone
pub_type: 临床试验,杂志文章
doi:10.1016/j.bone.2015.07.001
更新日期:2015-12-01 00:00:00
abstract::Cortical bone, the dominant component of the human skeleton by volume, plays a key role in protecting bones from fracture. We analyzed the cortical bone effects of teriparatide treatment in postmenopausal women with osteoporosis who had previously received long-term alendronate (ALN) therapy or were treatment naïve (T...
journal_title:Bone
pub_type: 临床试验,杂志文章
doi:10.1016/j.bone.2013.11.011
更新日期:2014-02-01 00:00:00
abstract::Intermittent PTH increases trabecular bone mass in vivo by stimulating osteoblast differentiation to increase bone formation. The molecular events that mediate the anabolic effect of PTH on osteoblasts have not been characterized. We investigated if PTH regulated mRNA expression of proto-oncogenes, c-fos, c-jun, and c...
journal_title:Bone
pub_type: 杂志文章
doi:10.1016/8756-3282(95)00332-2
更新日期:1995-11-01 00:00:00
abstract::We previously reported that a type II sodium phosphate (Na(+)-Pi) cotransporter (Npt2) protein is expressed in osteoclasts and that Pi limitation decreases osteoclast-mediated bone resorption in vitro. We also demonstrated that mice homozygous for the disrupted Npt2 gene (Npt2-/-) exhibit a unique age-dependent bone p...
journal_title:Bone
pub_type: 杂志文章
doi:10.1016/s8756-3282(01)00601-9
更新日期:2001-11-01 00:00:00
abstract::Profound bone loss at weight bearing sites is a primary effect of long-duration spaceflight. Moreover, a significant increase in estimated fracture risk remains even 1 year after returning to Earth; hence, it is important to define how quickly bone integrity can recover following prolonged disuse. This study character...
journal_title:Bone
pub_type: 杂志文章
doi:10.1016/j.bone.2012.09.021
更新日期:2013-01-01 00:00:00
abstract::Hypercalcemia results from an imbalance between the fluxes of calcium (Ca) entering and leaving the extracellular space. The two most important influxes are the net intestinal Ca absorption and the net skeletal Ca resorption, whereas the renal excretion represents the main route of elimination. When produced in excess...
journal_title:Bone
pub_type: 杂志文章,评审
doi:
更新日期:1987-01-01 00:00:00
abstract::The responses of bone cells to skeletal loading are clearly an important factor in bone biology, but much remains to be learned about the role of these responses in skeletal development, maintenance, and tissue repair. Bone morphogenetic proteins (BMPs) are key regulators of bone formation. We examined the effect of B...
journal_title:Bone
pub_type: 杂志文章
doi:10.1016/s8756-3282(02)00865-7
更新日期:2002-11-01 00:00:00
abstract::Although basic fibroblast growth factor (bFGF) is a potent stimulator of bone formation when administered intravenously, less is known regarding the effects of this peptide on bone following subcutaneous (s.c.) administration. In addition, it is unknown whether coadministration of estrogen enhances the bone response t...
journal_title:Bone
pub_type: 杂志文章
doi:10.1016/s8756-3282(03)00118-2
更新日期:2003-09-01 00:00:00
abstract::The objective was to quantify the outcome of osteoporosis (OP) in terms of health-related quality of life (HR-QOL) and cost of ambulatory care and to look at the association between these two outcomes variables. A cross-sectional health survey of 4800 Belgian individuals over the age of 45 years was used. Individuals ...
journal_title:Bone
pub_type: 杂志文章
doi:10.1016/s8756-3282(03)00089-9
更新日期:2003-06-01 00:00:00
abstract::Acceleration of remodeling activity after menopause leads to bone loss and fragility, however, whether this is associated with modifications of bone matrix quality has been less studied. The impact of variation in bone remodeling rate on bone matrix has been studied mainly in pathologies or anti-osteoporotic treatment...
journal_title:Bone
pub_type: 杂志文章
doi:10.1016/j.bone.2019.08.003
更新日期:2019-11-01 00:00:00
abstract::Genetic heterogeneity, high burden and the paucity of genetic testing for rare diseases challenge genomic healthcare for these disorders in India. Here we report our experience over the past decade, of establishing the genomic evaluation of skeletal dysplasia at a tertiary university hospital in India. Research or cli...
journal_title:Bone
pub_type: 杂志文章
doi:10.1016/j.bone.2018.10.026
更新日期:2019-03-01 00:00:00
abstract::The long prevailing view that obesity is generally associated with beneficial effects on the skeleton has recently been challenged. Apolipoprotein E (apoE) is known to influence both adipose tissue and bone. The goal of the current study was to examine the impact of apoE on the development of fat mass and bone mass in...
journal_title:Bone
pub_type: 杂志文章
doi:10.1016/j.bone.2010.07.002
更新日期:2010-10-01 00:00:00
abstract::This cohort study of postmenopausal women in the United Kingdom aged ≥50years determined the incremental cost of health care and clinical outcomes in the 12months following incident, selected fractures (non-vertebral non-hip [NVNHF], vertebral [VF] and multiple [MF]). Incremental costs and outcomes of the fracture coh...
journal_title:Bone
pub_type: 杂志文章
doi:10.1016/j.bone.2012.05.020
更新日期:2012-09-01 00:00:00
abstract:BACKGROUND AND OBJECTIVES:Chronic kidney disease (CKD) is commonly associated with mineral and bone metabolism disorders, but these are less frequently studied in non-dialysis CKD patients than in dialysis patients. We examined and described international variation in mineral and bone disease (MBD) markers and their tr...
journal_title:Bone
pub_type: 杂志文章
doi:10.1016/j.bone.2019.115058
更新日期:2019-12-01 00:00:00
abstract:PURPOSE:Traditional epidemiological studies suggest that there is an association between age at menarche (years) (AAM) and bone mineral density (BMD) at the sites of the femoral neck and lumbar spine (FNK and LS BMD), indicating a potentially important relationship between AAM and the development of osteoporosis (OP). ...
journal_title:Bone
pub_type: 杂志文章
doi:10.1016/j.bone.2018.09.015
更新日期:2018-12-01 00:00:00
abstract::The aims of this study were to clarify the role of cell maturation stage on chondrocyte response to parathyroid hormone (PTH) by examining the effect of PTH(1-34) on alkaline-phosphatase-specific activity (ALPase) of chondrocyte cultures at two distinct stages of maturation, and to determine the signaling pathways use...
journal_title:Bone
pub_type: 杂志文章
doi:10.1016/s8756-3282(97)00123-3
更新日期:1997-09-01 00:00:00
abstract::The role of prostaglandins (PGs) in physiological remodeling has not yet been defined. The present study was undertaken to determine whether they intervene during the activation phase in a highly reproducible and synchronized model of bone remodeling. Indomethacin was employed to inhibit PG synthesis. This treatment t...
journal_title:Bone
pub_type: 杂志文章
doi:10.1016/8756-3282(88)90003-8
更新日期:1988-01-01 00:00:00
abstract::Female Wistar rats aged 3 months were ovariectomized (OX, n = 27). Three months later they were given i.v. doses of 150 (6), 300 (7), or 600 (6) ug/kg 2/wk of olpadronate during 12 weeks or left as OX controls (OXc). Bending fracture load of femur diaphyses, reduced in OXc, was recovered by olpadronate. This effect wa...
journal_title:Bone
pub_type: 杂志文章
doi:10.1016/8756-3282(95)00314-4
更新日期:1995-10-01 00:00:00